Related Experiment Videos
[Does macular hole formation have a hormonal cause?]
M Kmera-Muszyńska1, W Zgliczyński
1Katedry i Kliniki Okulistyki II Wydziału Lekarskiego AM w Warszawie, Szpital Praski.
Klinika Oczna
|December 29, 2000
Summary
Postmenopausal women with macular holes show normal bone health and hormone levels, except for lower growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Further research is needed to understand these specific hormonal differences.
Area of Science:
- Ophthalmology
- Endocrinology
- Bone Metabolism
Background:
- Idiopathic macular holes are a common cause of vision impairment in older adults.
- Hormonal changes and bone metabolism alterations are prevalent in postmenopausal women.
Purpose of the Study:
- To investigate potential hormonal deficiencies (estradiol, gonadotrophins, growth hormone, IGF-1) in women with idiopathic macular holes.
- To assess calcium and phosphate metabolism and bone density in these patients compared to controls.
Main Methods:
- Blood samples were analyzed for estradiol (E2), LH, FSH, and IGF-1 in 16 postmenopausal women (65-72 years) with macular holes.
- Serum and 24-hour urine calcium and phosphate levels, alkaline phosphatase activity, and bone densitometry were evaluated.
Main Results:
- Hormone levels for E2, LH, and FSH were comparable to age-matched controls.
- Markers of calcium-phosphate metabolism and bone mineral density were within normal ranges.
- Significantly lower serum growth hormone (GH) and IGF-1 levels were observed in women with macular holes.
Conclusions:
- Postmenopausal women with idiopathic macular holes exhibit normal bone metabolism and density.
- Estradiol, LH, and FSH levels are similar to controls, suggesting these hormones are not primary factors.
- Reduced GH and IGF-1 in macular hole patients warrant further investigation into their role.